Author:
Staehler Michael,Haseke Nico,Zilinberg Ekaterina,Stadler Thomas,Karl Alexander,Siebels Michael,Dürr Hans-Roland,Siegert Sabine,Jauch Karl W.,Bruns Christiane J.,Stief Christian G.
Reference16 articles.
1. SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site [database on the Internet] 2008.
2. Sunitinib versus interferon-α in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007
3. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007
4. A phase I study to evaluate safety, immunogenicity and anti-tumor activity of the multi-peptide vaccine IMA901 in renal cell carcinoma patients (RCC);Staehler;J Clin Oncol,2007
5. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma;McDermott;J Clin Oncol,2005
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献